Name: Nutraceutical Excipients Market by Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Fillers & Diluents, Disintegrants, Coating Agents), End Product, Formulation, Functionality Application and Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: FB6004
Price: 4950 USD
Availability: InStock

報告摘要

The nutraceutical excipients market is estimated to be valued at USD 4.98 billion in 2025 and is projected to reach USD 7.12 billion by 2030, growing at a CAGR of 7.4% during the forecast period. The nutraceutical excipients market is projected to witness steady expansion through 2030, driven by the surging demand for high-quality, clean-label, and science-backed dietary supplements across global consumer groups. As brands innovate with advanced dosage forms—including gummies, softgels, controlled-release tablets, and functional beverages—there is a growing need for excipients that enhance stability, bioavailability, taste, and overall product performance. Rising health consciousness, coupled with the shift toward plant-based, natural, and allergen-free ingredients, is accelerating the adoption of novel excipients sourced from botanical and sustainable materials. Technological advancements such as plant-based capsule systems, multifunctional excipient blends, and improved solubility enhancers, supported by strong regulatory frameworks in regions like Europe and North America, are further propelling market growth. With increasing investments in R&D, formulation innovation, and manufacturing modernization, the nutraceutical excipients industry is emerging as a key enabler of high-performance and consumer-centric supplement development within the broader health and nutrition landscape. “The dry formulation segment is estimated to witness a significant share during the forecast period.” The dry nutraceutical excipients segment continues to dominate the market as manufacturers increasingly adopt powder-based ingredients for enhanced stability, extended shelf life, and ease of processing in tablets, capsules, and sachets. Dry excipients such as microcrystalline cellulose (MCC), lactose monohydrate, maltodextrin, prebiotic fibers, and silicon dioxide remain widely used for their superior flowability, compressibility, and bulking properties. Growing demand for clean-label and plant-derived nutraceuticals has also accelerated the use of bio-based dry excipients, including organic rice flour, acacia gum, and natural starch derivatives. Recent industry examples include Roquette’s launch of LYCOAT NG starch excipient for nutraceutical films in 2024, DFE Pharma’s expansion of its dry powder excipients portfolio for dietary supplements, and BASF’s introduction of dry-coated solutions to improve tablet performance. These innovations are strengthening the role of dry excipients as essential functional ingredients supporting formulation efficiency and high-quality nutraceutical product development. “The taste masking functionality segment is the fastest to maintain robust growth.” Taste masking has become the fastest-growing functionality in the nutraceutical excipients market as brands increasingly incorporate bitter plant extracts, minerals, amino acids, and next-generation bioactives into consumer-friendly formats. With rising demand for gummies, chewables, effervescent, and orally disintegrating powders, manufacturers now rely on excipients that can effectively reduce bitterness, metallic notes, and strong herbal flavors. This shift has accelerated the use of cyclodextrins for inclusion complexation, lipid-based carriers to block taste receptor interaction, and modified starches for microencapsulation. New developments are reinforcing this momentum, such as Ingredion’s 2024 clean-label encapsulation starches for flavor modulation, Ashland’s recent Klucel HPC grades optimized for taste-masked chewables, and Kerry’s release of Enmask™ natural flavor-modulating systems for active-rich supplements. As consumer expectations for pleasant-tasting nutraceuticals rise—especially in pediatric, sports nutrition, and women’s health products—taste masking is rapidly becoming a critical performance driver, solidifying its position as the fastest-expanding application area in nutraceutical excipients. “Europe is estimated to account for a significant share of the nutraceutical excipients market.” Europe holds a significant share in the nutraceutical excipients market, driven by the strong presence of leading global players and a steady rise in innovative product launches across the region. Countries such as Germany, France, the UK, and Switzerland serve as key hubs for pharmaceutical and nutraceutical manufacturing, supported by advanced R&D capabilities and strict quality standards that encourage the development of next-generation excipients. Major companies like Roquette, BASF, Kerry, and IMCD continue to expand their portfolios, with recent launches such as Roquette’s LYCAGEL® Flex softgel capsule shell system introduced at Vitafoods Europe 2024, reinforcing the region’s leadership in plant-based and functional excipient solutions. These innovations cater to Europe’s rapidly growing demand for vegan, clean-label, and high-performance nutraceutical formulations. The combination of well-established excipient manufacturers, continuous technological advancements, and a strong regulatory framework firmly positions Europe as a dominant and fast-evolving market for nutraceutical excipients. In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical excipients market: • By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30% • By Designation: Directors - 20%, Managers - 50%, Executives - 30% • By Region: North America - 25%, Europe - 30%, Asia Pacific - 20%, South America - 15%, and Rest of the World (Middle East and Africa) - 10% Prominent companies in the market include International Flavors & Fragrances Inc. (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc. (US), SEPPIC (US), and Azelis Group (Luxembourg). Research Coverage This research report categorizes the nutraceutical excipients market by source (organic chemicals, inorganic chemicals, others), functionality (disintegrants, colorants, lubricants & glidants, preservatives, emulsifying agents, other functionalities), end product (proteins & amino acids, omega-3 fatty acids, vitamins, minerals, prebiotics, probiotics, other end products), form (dry, liquid), functionality application (taste masking, stabilizers, modified release, solubility & bioavailability enhancers, other functionality applications), and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the nutraceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, and agreements. The study includes new product & service launches, mergers & acquisitions, and recent developments associated with the nutraceutical excipients market. This report also includes a competitive analysis of emerging startups in the nutraceutical excipients market ecosystem. Reasons to Buy this Report The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical excipients and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following points: 1. In-depth Segmentation across Type, Source, and Application: This study presents a detailed breakdown of the nutraceutical excipients market, categorizing it source (organic chemicals, inorganic chemicals, others), functionality (Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, Other Functionalities), end product (Proteins & Amino Acids, Omega-3 Fatty Acids, Vitamins, Minerals, Prebiotics, Probiotics, Other End Products). The analysis also covers key functional roles such as taste masking agents, stabilizers, solubilizers, and release-modifying excipients. This holistic segmentation enables stakeholders to identify high-growth formulation areas, enhance product development strategies, and align offerings with evolving nutraceutical manufacturing needs. 2. Region-specific Insights with Focus on Emerging Markets: The report offers an in-depth regional and country-level assessment, highlighting expanding opportunities across high-growth regions such as the Asia Pacific, South America, and the Middle East. It examines regulatory frameworks, clean-label norms, and consumer shifts toward plant-based, vegan, and natural supplements, driving excipient adoption. Additionally, it outlines government support for nutraceutical manufacturing, investments in advanced processing technologies, and rising local production capabilities—providing valuable guidance for companies seeking to scale, partner locally, or strengthen regional presence. 3. Competitive Intelligence and Innovation Landscape: Detailed competitive profiles of leading players—including Roquette, Kerry Group, BASF, Ingredion, and DSM—are provided, covering their strategic initiatives, technological advancements, and expansion plans. The report tracks major market developments such as product launches, facility expansions, mergers and acquisitions, and R&D activities. These insights equip stakeholders to benchmark competition, understand innovation trajectories, and capitalize on emerging formulation technologies shaping the nutraceutical excipients market. 4. Demand Forecasts Backed by Data-driven Methodologies: Market size projections and growth estimates through 2030 are based on validated top-down and bottom-up analytical approaches, supplemented by industry expert inputs and verified trade data. The forecasts deliver reliable insights into demand patterns, excipient consumption trends across dosage forms, and long-term market opportunities, helping stakeholders strategize investments and strengthen future-ready portfolios.

目錄 Table of Contents

1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.3 STUDY SCOPE 36 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 36 1.3.2 INCLUSIONS AND EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.4 UNITS CONSIDERED 39 1.4.1 CURRENCY CONSIDERED 39 1.5 STAKEHOLDERS 39 1.6 SUMMARY OF CHANGES 40 2 EXECUTIVE SUMMARY 41 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 43 2.3 DISRUPTIVE TRENDS SHAPING MARKET 44 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 45 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 46 3 PREMIUM INSIGHTS 48 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET 48 3.2 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE AND REGION 49 3.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 50 3.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 50 3.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE 51 3.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 51 3.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 52 3.8 NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 52 4 MARKET OVERVIEW 53 4.1 INTRODUCTION 53 4.2 MARKET DYNAMICS 53 4.2.1 DRIVERS 54 4.2.1.1 Increased focus on preventive care to encourage investments in products/solutions 54 4.2.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients 55 4.2.1.3 Rising investments in clean-label and natural excipients driven by regulatory pressure and shifting consumer health preferences 56 4.2.1.4 Mandates on food fortification by government organizations 57 4.2.2 RESTRAINTS 58 4.2.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration 58 4.2.2.2 Stringent regulatory expectations for excipient safety, purity, and compliance, adding complexity to product approvals 59 4.2.3 OPPORTUNITIES 59 4.2.3.1 Multi-functionalities of excipients aiding in saving costs and processing time 59 4.2.3.2 Rising awareness of micronutrient deficiencies 60 4.2.3.3 Growing popularity of gummy supplements 61 4.2.4 CHALLENGES 61 4.2.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers’ perception of dietary supplements as pharmaceutical drugs 61 4.2.4.2 Ensuring compatibility with high-potency actives 62 4.3 UNMET NEEDS AND WHITE SPACES 63 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65 5 INDUSTRY TRENDS 67 5.1 INTRODUCTION 67 5.2 PORTER’S FIVE FORCES ANALYSIS 67 5.2.1 INTENSITY OF COMPETITIVE RIVALRY 68 5.2.2 BARGAINING POWER OF SUPPLIERS 69 5.2.3 BARGAINING POWER OF BUYERS 69 5.2.4 THREAT OF SUBSTITUTES 69 5.2.5 THREAT OF NEW ENTRANTS 70 5.3 MACROECONOMIC INDICATORS 70 5.3.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 70 5.3.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS 71 5.4 SUPPLY CHAIN ANALYSIS 72 5.5 VALUE CHAIN ANALYSIS 73 5.5.1 SOURCING OF RAW MATERIALS 74 5.5.2 MANUFACTURING 74 5.5.3 DISTRIBUTION, MARKETING, AND SALES 74 5.6 ECOSYSTEM/MARKET MAP 74 5.6.1 UPSTREAM 74 5.6.1.1 Excipient manufacturers 74 5.6.1.2 Technology providers 74 5.6.2 DOWNSTREAM 75 5.6.2.1 Regulatory bodies 75 5.6.2.2 Nutraceutical manufacturers 75 5.7 PRICING ANALYSIS 77 5.7.1 INDICATIVE AVERAGE SELLING PRICE, BY SOURCE 77 5.7.2 AVERAGE SELLING PRICE TREND, BY REGION 78 5.8 TRADE ANALYSIS 79 5.8.1 TRADE ANALYSIS OF HS CODE 210690 79 5.8.1.1 Export trends of nutraceutical excipient under HS Code 210690 80 5.8.1.2 Import trends of nutraceutical excipients under HS Code 210690 80 5.8.2 TRADE ANALYSIS OF HS CODE 300490 81 5.8.2.1 Export trends of nutraceutical excipients under HS Code 300490 81 5.8.2.2 Import trends of nutraceutical excipients under HS Code 300490 82 5.8.3 TRADE ANALYSIS OF HS CODE 293090 83 5.8.3.1 Export trends of nutraceutical excipient under HS Code 293090 83 5.8.3.2 Import trends of nutraceutical excipients under HS Code 293090 84 5.8.4 TRADE ANALYSIS OF HS CODE 382200 84 5.8.4.1 Export trends of nutraceutical excipient under HS Code 382200 85 5.8.4.2 Import trends of nutraceutical excipient under HS Code 382200 85 5.9 KEY CONFERENCES & EVENTS 86 5.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 87 5.11 INVESTMENT AND FUNDING SCENARIO 88 5.12 CASE STUDY ANALYSIS 88 5.12.1 BENEO’S GALENIQ® MULTIFUNCTIONAL FILLER-BINDER FOR CLEAN-LABEL TABLETS (CPHI 2025) 88 5.12.2 ROQUETTE READILYCOAT® LOW-TEMPERATURE COATING SYSTEM (2025) 88 5.12.3 EVONIK – LIPID-BASED CARRIER FOR OMEGA-3 CAPSULES (APRIL 2024) 89 5.13 IMPACT OF 2025 US TARIFF - NUTRACEUTICAL EXCIPIENTS MARKET 89 5.13.1 INTRODUCTION 89 5.13.2 KEY TARIFF RATES 90 5.13.3 PRICE IMPACT ANALYSIS 90 5.13.4 IMPACT ON COUNTRY/REGION 91 5.13.5 IMPACT ON END-USE INDUSTRY 92 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 93 6.1 INTRODUCTION 93 6.2 KEY EMERGING TECHNOLOGIES 93 6.3 COMPLEMENTARY TECHNOLOGIES 94 6.4 TECHNOLOGY/PRODUCT ROADMAP 96 6.5 PATENT ANALYSIS 97 6.5.1 LIST OF MAJOR PATENTS 98 6.6 FUTURE APPLICATIONS 103 6.7 IMPACT OF AI/GEN AI ON NUTRACEUTICAL EXCIPIENTS MARKET 104 6.7.1 TOP USE CASES AND MARKET POTENTIAL 104 6.7.2 BEST PRACTICES IN NUTRACEUTICAL EXCIPIENT PROCESSING 105 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL EXCIPIENTS MARKET 106 6.7.3.1 AI-driven Ingredient Discovery & Formulation Optimization 106 6.7.3.2 AI-Enabled Evidence Review and Product Rationalization (2025) 106 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 107 6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL EXCIPIENTS MARKET 107 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 108 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 109 7.1 INTRODUCTION 109 7.2 REGIONAL REGULATIONS AND COMPLIANCE 109 7.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 7.2.2 INDUSTRY STANDARDS 113 7.2.2.1 Organizations/Regulations governing nutraceutical excipients market 113 7.2.2.2 North America 114 7.2.2.2.1 Canada 114 7.2.2.2.2 US 114 7.2.2.2.3 Mexico 115 7.2.2.3 European Union (EU) 115 7.2.2.4 Asia Pacific 115 7.2.2.4.1 Japan 115 7.2.2.4.2 China 115 7.2.2.4.3 India 116 7.2.2.4.4 Australia & New Zealand 116 7.2.2.5 Rest of the World (RoW) 116 7.2.2.5.1 Brazil 116 7.2.2.6 Probiotics 116 7.2.2.6.1 Introduction 116 7.2.2.6.2 National/International bodies for safety standards and regulations 117 7.2.2.6.3 Codex Alimentarius Commission (CAC) 117 7.2.2.6.4 North America: regulatory environment analysis 117 7.2.2.6.4.1 US 118 7.2.2.6.4.2 Canada 119 7.2.2.6.5 Asia Pacific: Regulatory environment analysis 119 7.2.2.6.5.1 Japan 120 7.2.2.6.5.2 India 120 7.2.2.6.6 South America: Regulatory Environment Analysis 121 7.2.2.6.6.1 Brazil 121 7.2.2.7 Prebiotics 121 7.2.2.7.1 Introduction 121 7.2.2.7.2 Asia Pacific 121 7.2.2.7.2.1 Japan 121 7.2.2.7.2.2 Australia & New Zealand 121 7.2.2.7.2.3 South Korea 122 7.2.2.7.2.4 India 122 7.2.2.7.3 North America 122 7.2.2.7.3.1 US 122 7.2.2.7.3.2 Canada 122 7.2.2.7.4 European Union 124 7.3 SUSTAINABILITY INITIATIVES 124 7.3.1 ADOPTION OF PLANT-BASED AND UPCYCLED RAW MATERIALS 124 7.3.2 IMPLEMENTATION OF ENERGY-EFFICIENT PROCESSING TECHNOLOGIES 126 7.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 127 7.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 127 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 130 8.1 INTRODUCTION 130 8.2 DECISION-MAKING PROCESS 130 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 131 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 131 8.3.2 BUYING CRITERIA 132 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 134 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 134 8.6 MARKET PROFITABILITY 135 9 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 136 9.1 INTRODUCTION 137 9.2 PROBIOTICS 138 9.2.1 GROWING STABILITY REQUIREMENTS OF PROBIOTIC INGREDIENTS TO DRIVE MARKET 138 9.3 PREBIOTICS 140 9.3.1 INCREASING FORMULATION NEEDS FOR STABLE PREBIOTIC INGREDIENTS TO DRIVE MARKET 140 9.4 PROTEINS & AMINO ACIDS 141 9.4.1 GROWING FORMULATION REQUIREMENTS FOR STABLE PROTEIN AND AMINO ACID INGREDIENTS TO DRIVE MARKET 141 9.5 VITAMINS 142 9.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS 142 9.6 MINERALS 144 9.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 144 9.7 OMEGA-3 FATTY ACIDS 145 9.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACID SUPPLEMENTS 145 9.8 OTHER END PRODUCTS 146 10 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE 148 10.1 INTRODUCTION 149 10.2 ORGANIC CHEMICALS 150 10.2.1 OLEOCHEMICALS 151 10.2.1.1 Fatty alcohols 152 10.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand 152 10.2.1.2 Mineral stearates 153 10.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals 153 10.2.1.3 Glycerin 153 10.2.1.3.1 Glycerin to help improve smoothness and lubrication process 153 10.2.1.4 Other oleochemicals 153 10.2.2 CARBOHYDRATES 153 10.2.2.1 Sugars 154 10.2.2.1.1 Actual sugars 155 10.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose 155 10.2.2.1.2 Sugar alcohols 156 10.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them an attractive option 156 10.2.2.1.3 Artificial sweeteners 156 10.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand 156 10.2.2.2 Cellulose 157 10.2.2.2.1 Microcrystalline cellulose 158 10.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity 158 10.2.2.2.2 Cellulose ethers 158 10.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology 158 10.2.2.2.3 CMC & croscarmellose sodium 159 10.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth 159 10.2.2.2.4 Cellulose esters 159 10.2.2.2.4.1 Rising demand for cellulose esters to provide a technical edge in nutraceuticals 159 10.2.2.3 Starch 159 10.2.2.3.1 Modified starch 160 10.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceutical excipient industry 160 10.2.2.3.2 Dried starch 161 10.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market 161 10.2.2.3.3 Converted starch 161 10.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption 161 10.2.3 PETROCHEMICALS 161 10.2.3.1 Glycols 162 10.2.3.1.1 Humectant & solvent properties to drive demand 162 10.2.3.2 Povidones 163 10.2.3.2.1 Film-forming function to provide controlled release of active ingredients 163 10.2.3.3 Mineral hydrocarbons 163 10.2.3.3.1 Properties such as antifoaming and lubrication to help in nutraceutical manufacturing 163 10.2.3.4 Acrylic polymers 163 10.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth 163 10.2.3.5 Other petrochemical excipients 164 10.2.4 PROTEINS 164 10.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth 164 10.2.5 OTHER ORGANIC CHEMICALS 164 10.3 INORGANIC CHEMICALS 165 10.3.1 CALCIUM PHOSPHATE 166 10.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients 166 10.3.2 METAL OXIDES 166 10.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals 166 10.3.3 HALITES 167 10.3.3.1 Halites to ensure taste improvement and salting-out techniques 167 10.3.4 CALCIUM CARBONATE 167 10.3.4.1 Focus on R&D of calcium carbonate to help launch new products 167 10.3.5 CALCIUM SULFATE 168 10.3.5.1 Improved flowability to drive demand for calcium sulfate 168 10.3.6 OTHER INORGANIC CHEMICALS 168 10.4 OTHER CHEMICALS 168 11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 170 11.1 INTRODUCTION 171 11.2 TASTE MASKING 172 11.2.1 CREATING DIFFERENTIATION IS KEY IN THIS COMPETITIVE MARKET 172 11.3 STABILIZERS 173 11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS 173 11.4 MODIFIED RELEASE 174 11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATIONS IN NUTRACEUTICAL EXCIPIENTS MARKET 174 11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 175 11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND 175 11.6 OTHER FUNCTIONALITY APPLICATIONS 177 12 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 178 12.1 INTRODUCTION 179 12.2 DRY 180 12.2.1 TABLETS 182 12.2.1.1 Easy-to-carry and portable nature makes them attractive option 182 12.2.2 CAPSULES 182 12.2.2.1 Quick-dissolving capsule shells for targeted absorption are ideal for nutraceuticals designed to act in specific areas of digestive tract 182 12.3 LIQUID 183 12.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH 183 12.4 OTHER FORMULATIONS 184 13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 185 13.1 INTRODUCTION 186 13.2 BINDERS 188 13.2.1 INCREASED ACCEPTANCE AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 188 13.3 FILLERS & DILUENTS 189 13.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS 189 13.4 DISINTEGRANTS 190 13.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT 190 13.5 COATING AGENTS 191 13.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND 191 13.6 FLAVORING AGENTS & SWEETENERS 192 13.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT 192 13.7 PRESERVATIVES 193 13.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES 193 13.8 LUBRICANTS & GLIDANTS 194 13.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT 194 13.9 SUSPENDING & VISCOSITY AGENTS 195 13.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT 195 13.10 COLORANTS 196 13.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS 196 13.11 EMULSIFYING AGENTS 197 13.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS 197 13.12 OTHER FUNCTIONALITIES 198 14 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 200 14.1 INTRODUCTION 201 14.2 NORTH AMERICA 204 14.2.1 US 209 14.2.1.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US 209 14.2.2 CANADA 210 14.2.2.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada 210 14.2.3 MEXICO 212 14.2.3.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements 212 14.3 EUROPE 213 14.3.1 GERMANY 218 14.3.1.1 Demand for nutraceutical excipients is likely to increase to serve health-conscious consumers 218 14.3.2 FRANCE 220 14.3.2.1 Innovations in product formulations to cater to increased consumer demands 220 14.3.3 UK 221 14.3.3.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients 221 14.3.4 ITALY 223 14.3.4.1 Growing trend of online OTC and food supplement purchases in Italy 223 14.3.5 SPAIN 224 14.3.5.1 Excipient manufacturers expand Iberian operations to support tablets and capsules marketed across Spain 224 14.3.6 REST OF EUROPE 226 14.4 ASIA PACIFIC 227 14.4.1 CHINA 233 14.4.1.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products 233 14.4.2 JAPAN 235 14.4.2.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan 235 14.4.3 INDIA 236 14.4.3.1 Government policies and importance of nutraceuticals in daily life 236 14.4.4 SOUTH KOREA 238 14.4.4.1 Rapid growth of supplements industry in South Korea 238 14.4.5 REST OF ASIA PACIFIC 240 14.5 SOUTH AMERICA 241 14.5.1 BRAZIL 246 14.5.1.1 Growth in awareness regarding the benefits of functional foods and rise in aging population in Brazil 246 14.5.2 ARGENTINA 247 14.5.2.1 Country’s focus on prevention healthcare system to be positive sign for nutraceutical excipients market 247 14.5.3 REST OF SOUTH AMERICA 249 14.6 REST OF THE WORLD (ROW) 250 14.6.1 MIDDLE EAST 255 14.6.1.1 Rise in obesity and other health-related concerns in Middle East 255 14.6.2 AFRICA 256 14.6.2.1 Intra-African trade policies and investments by global nutraceutical players 256 15 COMPETITIVE LANDSCAPE 258 15.1 OVERVIEW 258 15.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2024 259 15.3 REVENUE ANALYSIS, 2022–2024 261 15.4 MARKET SHARE ANALYSIS, 2024 262 15.5 BRAND/PRODUCT COMPARISON 264 15.5.1 KERRY GROUP PLC (IRELAND) 264 15.5.2 INGREDION (US) 265 15.5.3 BASF (GERMANY) 265 15.5.4 ASSOCIATED BRITISH FOODS PLC (UK) 265 15.5.5 SENSIENT TECHNOLOGIES CORPORATION (US) 265 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 265 15.6.1 STARS 266 15.6.2 EMERGING LEADERS 266 15.6.3 PERVASIVE PLAYERS 266 15.6.4 PARTICIPANTS 266 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 268 15.6.5.1 Company footprint 268 15.6.5.2 Region footprint 269 15.6.5.3 Source footprint 270 15.6.5.4 Functionality footprint 271 15.6.5.5 Functionality application footprint 272 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 273 15.7.1 PROGRESSIVE COMPANIES 273 15.7.2 RESPONSIVE COMPANIES 273 15.7.3 DYNAMIC COMPANIES 273 15.7.4 STARTING BLOCKS 273 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 275 15.7.5.1 Detailed list of key startups/SMEs 275 15.7.5.2 Competitive benchmarking of key startups/SMEs 276 15.8 COMPANY VALUATION AND FINANCIAL METRICS 277 15.8.1 COMPANY VALUATION 277 15.8.2 EV/EBITDA 277 15.9 COMPETITIVE SCENARIO 278 15.9.1 PRODUCT LAUNCHES 278 15.9.2 DEALS 279 15.9.3 EXPANSIONS 282 15.9.4 OTHER DEVELOPMENTS 283 16 COMPANY PROFILES 284 16.1 KEY PLAYERS 284 16.1.1 KERRY GROUP PLC 284 16.1.1.1 Business overview 284 16.1.1.2 Product/Solutions/Services offered 285 16.1.1.3 Recent developments 287 16.1.1.4 MnM view 288 16.1.1.4.1 Right to win 288 16.1.1.4.2 Strategic choices 288 16.1.1.4.3 Weaknesses and competitive threats 288 16.1.2 INGREDION 289 16.1.2.1 Business overview 289 16.1.2.2 Product/Solutions/Services offered 290 16.1.2.3 Recent developments 291 16.1.2.3.1 Deals 291 16.1.2.4 MnM view 291 16.1.2.4.1 Right to win 291 16.1.2.4.2 Strategic choices 291 16.1.2.4.3 Weaknesses and competitive threats 292 16.1.3 BASF SE 293 16.1.3.1 Business overview 293 16.1.3.2 Product/Solutions/Services offered 294 16.1.3.3 Recent developments 295 16.1.3.3.1 Deals 295 16.1.3.3.2 Other developments 296 16.1.3.4 MnM view 296 16.1.3.4.1 Right to win 296 16.1.3.4.2 Strategic choices 296 16.1.3.4.3 Weaknesses and competitive threats 297 16.1.4 ASSOCIATED BRITISH FOODS PLC 298 16.1.4.1 Business overview 298 16.1.4.2 Product/Solutions/Services offered 299 16.1.4.3 Recent developments 301 16.1.4.3.1 Product launches 301 16.1.4.4 MnM view 302 16.1.4.4.1 Right to win 302 16.1.4.4.2 Strategic choices 302 16.1.4.4.3 Weaknesses and competitive threats 302 16.1.5 SENSIENT TECHNOLOGIES CORPORATION 303 16.1.5.1 Business overview 303 16.1.5.2 Product/Solutions/Services offered 304 16.1.5.3 Recent developments 306 16.1.5.3.1 Deals 306 16.1.5.4 MnM view 307 16.1.5.4.1 Right to win 307 16.1.5.4.2 Strategic choices 307 16.1.5.4.3 Weaknesses and competitive threats 307 16.1.6 CARGILL, INCORPORATED 308 16.1.6.1 Business overview 308 16.1.6.2 Product/Solutions/Services offered 309 16.1.6.3 Recent developments 311 16.1.6.3.1 Expansions 311 16.1.6.4 MnM view 312 16.1.6.4.1 Right to win 312 16.1.6.4.2 Strategic choices 312 16.1.6.4.3 Weaknesses and competitive threats 312 16.1.7 AZELIS 313 16.1.7.1 Business overview 313 16.1.7.2 Product/Solutions/Services offered 314 16.1.7.3 Recent developments 315 16.1.7.3.1 Deals 315 16.1.7.3.2 Expansions 317 16.1.7.4 MnM view 318 16.1.7.4.1 Right to win 318 16.1.7.4.2 Strategic choices 318 16.1.7.4.3 Weaknesses and competitive threats 318 16.1.8 ASHLAND 319 16.1.8.1 Business overview 319 16.1.8.2 Product/Solutions/Services offered 320 16.1.8.3 Recent developments 322 16.1.8.3.1 Product launches 322 16.1.8.3.2 Other developments 322 16.1.8.4 MnM view 323 16.1.8.4.1 Right to win 323 16.1.8.4.2 Strategic choices 323 16.1.8.4.3 Weaknesses and competitive threats 323 16.1.9 MEGGLE HOLDING SE 324 16.1.9.1 Business overview 324 16.1.9.2 Product/Solutions/Services offered 324 16.1.9.3 Recent developments 326 16.1.9.3.1 Product launches 326 16.1.9.4 MnM view 327 16.1.9.4.1 Right to win 327 16.1.9.4.2 Strategic choices 327 16.1.9.4.3 Weaknesses and competitive threats 327 16.1.10 ROQUETTE FRÈRES 328 16.1.10.1 Business overview 328 16.1.10.2 Product/Solutions/Services offered 329 16.1.10.3 Recent developments 331 16.1.10.3.1 Product launches 331 16.1.10.3.2 Deals 333 16.1.10.3.3 Expansions 334 16.1.10.4 MnM view 335 16.1.10.4.1 Right to win 335 16.1.10.4.2 Strategic choices 336 16.1.10.4.3 Weaknesses and competitive threats 336 16.1.11 COLORCON, INC. 337 16.1.11.1 Business overview 337 16.1.11.2 Product/Solutions/Services offered 338 16.1.11.3 Recent developments 340 16.1.11.3.1 Product launches 340 16.1.11.3.2 Deals 340 16.1.11.3.3 Expansions 341 16.1.11.3.4 Other developments 342 16.1.11.4 MnM view 342 16.1.11.4.1 Right to win 342 16.1.11.4.2 Strategic choices 342 16.1.11.4.3 Weaknesses and competitive threats 342 16.1.12 ALSIANO A/S 343 16.1.12.1 Business overview 343 16.1.12.2 Product/Solutions/Services offered 343 16.1.12.3 Recent developments 346 16.1.12.4 MnM view 346 16.1.12.4.1 Right to win 346 16.1.12.4.2 Strategic choices 347 16.1.12.4.3 Weaknesses and competitive threats 347 16.1.13 JIGS CHEMICAL 348 16.1.13.1 Business overview 348 16.1.13.2 Product/Solutions/Services offered 348 16.1.13.3 MnM view 350 16.1.13.3.1 Right to win 350 16.1.13.3.2 Strategic choices 350 16.1.13.3.3 Weaknesses and competitive threats 350 16.1.14 IMCD 351 16.1.14.1 Business overview 351 16.1.14.2 Product/Solutions/Services offered 352 16.1.14.3 Recent developments 353 16.1.14.3.1 Deals 353 16.1.14.3.2 Expansions 355 16.1.14.4 MnM view 356 16.1.14.4.1 Right to win 356 16.1.14.4.2 Strategic choices 356 16.1.14.4.3 Weaknesses and competitive threats 356 16.1.15 HILMAR CHEESE COMPANY, INC. 357 16.1.15.1 Business overview 357 16.1.15.2 Product/Solutions/Services offered 357 16.1.15.3 Recent developments 358 16.1.15.3.1 Expansions 358 16.1.15.4 MnM view 359 16.1.15.4.1 Right to win 359 16.1.15.4.2 Strategic choices 359 16.1.15.4.3 Weaknesses and competitive threats 359 16.1.16 OMYA 360 16.1.16.1 Business overview 360 16.1.16.2 Product/Solutions/Services offered 360 16.1.16.3 Recent developments 361 16.1.16.3.1 Deals 361 16.1.16.4 MnM view 361 16.1.17 BIOGRUND 362 16.1.17.1 Business overview 362 16.1.17.2 Product/Solutions/Services offered 362 16.1.17.3 Recent developments 363 16.1.17.3.1 Deals 363 16.1.17.3.2 Expansions 364 16.1.17.4 MnM view 364 16.1.18 JRS PHARMA 365 16.1.18.1 Business overview 365 16.1.18.2 Product/Solutions/Services offered 365 16.1.18.3 Recent developments 367 16.1.18.3.1 Product launches 367 16.1.18.3.2 Expansions 367 16.1.18.4 MnM view 368 16.1.19 INNOPHOS 369 16.1.19.1 Business overview 369 16.1.19.2 Product/Solutions/Services offered 369 16.1.19.3 Recent developments 370 16.1.19.3.1 Expansions 370 16.1.19.4 MnM view 370 16.1.20 NOVO EXCIPIENTS PVT. LTD. 371 16.1.20.1 Business overview 371 16.1.20.2 Products offered 371 16.1.20.3 MnM view 372 16.1.21 PANCHAMRUT CHEMICALS 373 16.1.22 GATTEFOSSÉ 374 16.1.23 FUJI CHEMICAL INDUSTRIES CO., LTD. 375 16.1.24 SUDEEP PHARMA LIMITED 376 16.1.25 SŌRSE TECHNOLOGIES 377 17 RESEARCH METHODOLOGY 378 17.1 RESEARCH DATA 378 17.1.1 SECONDARY DATA 379 17.1.1.1 Key data from secondary sources 380 17.1.2 PRIMARY DATA 380 17.1.2.1 Key data from primary sources 381 17.1.2.2 Key primary participants 381 17.1.2.2.1 Nutraceutical excipients companies 381 17.1.2.3 Breakdown of primary interviews 382 17.1.2.4 Key industry insights 382 17.2 MARKET SIZE ESTIMATION 383 17.2.1 BOTTOM-UP APPROACH 384 17.2.2 TOP-DOWN APPROACH 385 17.2.3 TOP-DOWN APPROACH 387 17.3 DATA TRIANGULATION 388 17.4 FACTOR ANALYSIS 389 17.5 RESEARCH ASSUMPTIONS 390 17.6 RESEARCH LIMITATIONS 391 18 APPENDIX 392 18.1 DISCUSSION GUIDE 392 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 398 18.3 RELATED REPORTS 400 18.4 AUTHOR DETAILS 401

圖表清單 List of Tables & Figures

TABLE 1 INCLUSIONS AND EXCLUSIONS 37 TABLE 2 USD EXCHANGE RATES, 2020–2024 39 TABLE 3 GLOBAL PREVALENCE OF ANEMIA, 2024–2025 57 TABLE 4 UNMET NEEDS AND WHITE SPACES IN NUTRACEUTICAL EXCIPIENTS MARKET 63 TABLE 5 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64 TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65 TABLE 7 NUTRACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 67 TABLE 8 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 76 TABLE 9 INDICATIVE AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL EXCIPIENTS BY KEY PLAYERS, 2024 (USD/MT) 77 TABLE 10 INDICATIVE PRICING ANALYSIS FOR NUTRACEUTICAL EXCIPIENTS, BY SOURCE, 2023–2024 (USD/KG) 78 TABLE 11 AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2024 (USD/KG) 79 TABLE 12 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 86 TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 90 TABLE 14 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT 91 TABLE 15 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL EXCIPIENT 92 TABLE 16 TECHNOLOGY/PRODUCT MAP FOR NUTRACEUTICAL EXCIPIENTS MARKET 96 TABLE 17 LIST OF MAJOR PATENTS ABOUT NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2024 98 TABLE 18 NUTRACEUTICAL EXCIPIENTS MARKET: FUTURE APPLICATIONS 103 TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 22 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 23 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 24 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE 114 TABLE 25 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 117 TABLE 26 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS 122 TABLE 27 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 123 TABLE 28 KEY INDUSTRY STANDARDS FOR NUTRACEUTICAL EXCIPIENTS MARKET 124 TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT SOURCE 132 TABLE 30 KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT 133 TABLE 31 NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2020–2024 (USD MILLION) 138 TABLE 32 NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 138 TABLE 33 NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2020–2024 (USD MILLION) 139 TABLE 34 NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 139 TABLE 35 NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2020–2024 (USD MILLION) 140 TABLE 36 NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 141 TABLE 37 NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2020–2024 (USD MILLION) 142 TABLE 38 NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2025–2030 (USD MILLION) 142 TABLE 39 LIST OF NUTRIENTS AND THEIR RELEVANCE 143 TABLE 40 NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2020–2024 (USD MILLION) 143 TABLE 41 NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2025–2030 (USD MILLION) 144 TABLE 42 NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2020–2024 (USD MILLION) 145 TABLE 43 NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2025–2030 (USD MILLION) 145 TABLE 44 NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2020–2024 (USD MILLION) 146 TABLE 45 NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2025–2030 (USD MILLION) 146 TABLE 46 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2020–2024 (USD MILLION) 147 TABLE 47 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2025–2030 (USD MILLION) 147 TABLE 48 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 149 TABLE 49 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 150 TABLE 50 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 150 TABLE 51 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 151 TABLE 52 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 151 TABLE 53 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 151 TABLE 54 OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 152 TABLE 55 OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 152 TABLE 56 CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 154 TABLE 57 CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 154 TABLE 58 SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 155 TABLE 59 SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 155 TABLE 60 CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 157 TABLE 61 CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 157 TABLE 62 STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 160 TABLE 63 STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 160 TABLE 64 PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 162 TABLE 65 PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 162 TABLE 66 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 165 TABLE 67 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 165 TABLE 68 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 166 TABLE 69 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 166 TABLE 70 OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 169 TABLE 71 OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 169 TABLE 72 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 171 TABLE 73 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 171 TABLE 74 NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2020–2024 (USD MILLION) 173 TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2025–2030 (USD MILLION) 173 TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2020–2024 (USD MILLION) 174 TABLE 77 NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2025–2030 (USD MILLION) 174 TABLE 78 NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2020–2024 (USD MILLION) 175 TABLE 79 NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2025–2030 (USD MILLION) 175 TABLE 80 NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2020–2024 (USD MILLION) 176 TABLE 81 NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2025–2030 (USD MILLION) 176 TABLE 82 NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2020–2024 (USD MILLION) 177 TABLE 83 NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 177 TABLE 84 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 179 TABLE 85 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 179 TABLE 86 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 181 TABLE 87 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 181 TABLE 88 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2020–2024 (USD MILLION) 181 TABLE 89 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2025–2030 (USD MILLION) 182 TABLE 90 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 183 TABLE 91 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 183 TABLE 92 OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2020–2024 (USD MILLION) 184 TABLE 93 OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2025–2030 (USD MILLION) 184 TABLE 94 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 186 TABLE 95 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 187 TABLE 96 NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2020–2024 (USD MILLION) 188 TABLE 97 NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2025–2030 (USD MILLION) 188 TABLE 98 NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2020–2024 (USD MILLION) 189 TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2025–2030 (USD MILLION) 190 TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2020–2024 (USD MILLION) 191 TABLE 101 NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2025–2030 (USD MILLION) 191 TABLE 102 NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2020–2024 (USD MILLION) 192 TABLE 103 NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2025–2030 (USD MILLION) 192 TABLE 104 NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2020–2024 (USD MILLION) 193 TABLE 105 NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2025–2030 (USD MILLION) 193 TABLE 106 NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2020–2024 (USD MILLION) 194 TABLE 107 NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2025–2030 (USD MILLION) 194 TABLE 108 NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2020–2024 (USD MILLION) 195 TABLE 109 NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2025–2030 (USD MILLION) 195 TABLE 110 NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2020–2024 (USD MILLION) 196 TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025–2030 (USD MILLION) 196 TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2020–2024 (USD MILLION) 197 TABLE 113 NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2025–2030 (USD MILLION) 197 TABLE 114 NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2020–2024 (USD MILLION) 198 TABLE 115 NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2025–2030 (USD MILLION) 198 TABLE 116 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2020–2024 (USD MILLION) 199 TABLE 117 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2025–2030 (USD MILLION) 199 TABLE 118 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 202 TABLE 119 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 203 TABLE 120 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (KT) 203 TABLE 121 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (KT) 203 TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 205 TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 205 TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 205 TABLE 125 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 205 TABLE 126 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 206 TABLE 127 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 206 TABLE 128 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 207 TABLE 129 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 207 TABLE 130 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 207 TABLE 131 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 208 TABLE 132 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 208 TABLE 133 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 208 TABLE 134 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 209 TABLE 135 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 210 TABLE 136 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 211 TABLE 137 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 211 TABLE 138 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 212 TABLE 139 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 213 TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 214 TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 214 TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 215 TABLE 143 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 215 TABLE 144 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 215 TABLE 145 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 216 TABLE 146 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 216 TABLE 147 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 216 TABLE 148 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 217 TABLE 149 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 217 TABLE 150 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 217 TABLE 151 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 218 TABLE 152 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 219 TABLE 153 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 219 TABLE 154 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 220 TABLE 155 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 221 TABLE 156 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 222 TABLE 157 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 222 TABLE 158 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 223 TABLE 159 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 224 TABLE 160 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 225 TABLE 161 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 225 TABLE 162 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 226 TABLE 163 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 227 TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 228 TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 229 TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 229 TABLE 167 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 229 TABLE 168 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 230 TABLE 169 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 230 TABLE 170 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 231 TABLE 171 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 231 TABLE 172 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 231 TABLE 173 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 232 TABLE 174 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 232 TABLE 175 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 232 TABLE 176 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 234 TABLE 177 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 234 TABLE 178 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 235 TABLE 179 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 236 TABLE 180 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 237 TABLE 181 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 238 TABLE 182 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 239 TABLE 183 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 239 TABLE 184 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 240 TABLE 185 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 241 TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 242 TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 242 TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 242 TABLE 189 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 242 TABLE 190 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 243 TABLE 191 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 243 TABLE 192 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 244 TABLE 193 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 244 TABLE 194 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 244 TABLE 195 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 245 TABLE 196 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 245 TABLE 197 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 245 TABLE 198 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 246 TABLE 199 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 247 TABLE 200 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 248 TABLE 201 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 248 TABLE 202 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 249 TABLE 203 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 250 TABLE 204 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 251 TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 251 TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 251 TABLE 207 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 251 TABLE 208 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 252 TABLE 209 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 252 TABLE 210 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 253 TABLE 211 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 253 TABLE 212 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 253 TABLE 213 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 254 TABLE 214 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 254 TABLE 215 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 254 TABLE 216 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 255 TABLE 217 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 256 TABLE 218 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 257 TABLE 219 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 257 TABLE 220 COMPETITIVE STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2024 259 TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION 263 TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT 269 TABLE 223 NUTRACEUTICAL EXCIPIENTS MARKET: SOURCE FOOTPRINT 270 TABLE 224 NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT 271 TABLE 225 NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT 272 TABLE 226 NUTRACEUTICAL EXCIPIENTS MARKET: KEY STARTUPS/SMES 275 TABLE 227 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 276 TABLE 228 NUTRACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, 2020–NOVEMBER 2025 278 TABLE 229 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2020–NOVEMBER 2025 279 TABLE 230 NUTRACEUTICAL EXCIPIENTS MARKET: EXPANSIONS, 2020–NOVEMBER 2025 282 TABLE 231 NUTRACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, 2020–NOVEMBER 2025 283 TABLE 232 KERRY GROUP PLC: BUSINESS OVERVIEW 284 TABLE 233 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285 TABLE 234 KERRY GROUP PLC: DEALS 287 TABLE 235 KERRY GROUP PLC: EXPANSION 288 TABLE 236 INGREDION: BUSINESS OVERVIEW 289 TABLE 237 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290 TABLE 238 INGREDION: DEALS 291 TABLE 239 BASF SE: BUSINESS OVERVIEW 293 TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294 TABLE 241 BASF SE: DEALS 295 TABLE 242 BASF SE: OTHER DEVELOPMENTS 296 TABLE 243 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 298 TABLE 244 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 299 TABLE 245 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES 301 TABLE 246 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW 303 TABLE 247 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304 TABLE 248 SENSIENT TECHNOLOGIES CORPORATION: DEALS 306 TABLE 249 CARGILL, INCORPORATED: BUSINESS OVERVIEW 308 TABLE 250 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 309 TABLE 251 CARGILL, INCORPORATED: EXPANSIONS 311 TABLE 252 AZELIS: BUSINESS OVERVIEW 313 TABLE 253 AZELIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 314 TABLE 254 AZELIS: DEALS 315 TABLE 255 AZELIS: EXPANSIONS 317 TABLE 256 ASHLAND: BUSINESS OVERVIEW 319 TABLE 257 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 320 TABLE 258 ASHLAND: PRODUCT LAUNCHES 322 TABLE 259 ASHLAND: OTHER DEVELOPMENTS 322 TABLE 260 MEGGLE HOLDING SE: BUSINESS OVERVIEW 324 TABLE 261 MEGGLE HOLDING SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 324 TABLE 262 MEGGLE HOLDING SE: PRODUCT LAUNCHES 326 TABLE 263 ROQUETTE FRÈRES: BUSINESS OVERVIEW 328 TABLE 264 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 329 TABLE 265 ROQUETTE FRÈRES: PRODUCT LAUNCHES 331 TABLE 266 ROQUETTE FRÈRES: DEALS 333 TABLE 267 ROQUETTE FRÈRES: EXPANSIONS 334 TABLE 268 COLORCON, INC.: BUSINESS OVERVIEW 337 TABLE 269 COLORCON, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 338 TABLE 270 COLORCON, INC.: PRODUCT LAUNCHES 340 TABLE 271 COLORCON, INC.: DEALS 340 TABLE 272 COLORCON, INC.: EXPANSIONS 341 TABLE 273 COLORCON, INC.: OTHER DEVELOPMENTS 342 TABLE 274 ALSIANO A/S: BUSINESS OVERVIEW 343 TABLE 275 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 343 TABLE 276 ALSIANO A/S: DEALS 346 TABLE 277 JIGS CHEMICAL: BUSINESS OVERVIEW 348 TABLE 278 JIGS CHEMICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 348 TABLE 279 IMCD: BUSINESS OVERVIEW 351 TABLE 280 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 352 TABLE 281 IMCD: DEALS 353 TABLE 282 IMCD: EXPANSIONS 355 TABLE 283 HILMAR CHEESE COMPANY, INC.: BUSINESS OVERVIEW 357 TABLE 284 HILMAR CHEESE COMPANY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 357 TABLE 285 HILMAR CHEESE COMPANY, INC.: EXPANSIONS 358 TABLE 286 OMYA: BUSINESS OVERVIEW 360 TABLE 287 OMYA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 360 TABLE 288 OMYA: DEALS 361 TABLE 289 BIOGRUND: BUSINESS OVERVIEW 362 TABLE 290 BIOGRUND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 362 TABLE 291 BIOGRUND: DEALS 363 TABLE 292 BIOGRUND: EXPANSIONS 364 TABLE 293 JRS PHARMA: BUSINESS OVERVIEW 365 TABLE 294 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 365 TABLE 295 JRS PHARMA: PRODUCT LAUNCHES 367 TABLE 296 JRS PHARMA: EXPANSIONS 367 TABLE 297 INNOPHOS: BUSINESS OVERVIEW 369 TABLE 298 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 369 TABLE 299 INNOPHOS: EXPANSIONS 370 TABLE 300 NOVO EXCIPIENTS PVT. LTD.: BUSINESS OVERVIEW 371 TABLE 301 NOVO EXCIPIENTS PVT. LTD.: PRODUCTS OFFERED 371 TABLE 302 PANCHAMRUT CHEMICALS: COMPANY OVERVIEW 373 TABLE 303 GATTEFOSSÉ: COMPANY OVERVIEW 374 TABLE 304 FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW 375 TABLE 305 SUDEEP PHARMA LIMITED: COMPANY OVERVIEW 376 TABLE 306 SŌRSE TECHNOLOGIES: COMPANY OVERVIEW 377 FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION 36 FIGURE 2 STUDY YEARS CONSIDERED 38 FIGURE 3 KEY INSIGHTS AND MARKET HIGHLIGHTS 42 FIGURE 4 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2030 (USD MILLION) 42 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2025 43 FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD 44 FIGURE 7 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2025–2030 45 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 46 FIGURE 9 INCREASING DEMAND FOR HIGH-QUALITY EXCIPIENTS ENABLING EFFECTIVE TABLET AND CAPSULE NUTRACEUTICAL FORMULATIONS 48 FIGURE 10 ORGANIC CHEMICALS SEGMENT AND NORTH AMERICA ACCOUNTED FOR LARGEST SEGMENTAL SHARES IN 2024 49 FIGURE 11 NORTH AMERICA DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 50 FIGURE 12 DRY SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 50 FIGURE 13 ORGANIC CHEMICALS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 51 FIGURE 14 MODIFIED RELEASE SEGMENTS DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 51 FIGURE 15 PROBIOTICS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 52 FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52 FIGURE 17 NUTRACEUTICAL EXCIPIENTS MARKET DYNAMICS 53 FIGURE 18 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 55 FIGURE 19 PORTER’S FIVE FORCES ANALYSIS: NUTRACEUTICAL EXCIPIENTS MARKET 68 FIGURE 20 US: POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 72 FIGURE 21 KEY MARKET DRIVERS SHAPING INNOVATION, ADOPTION, AND GROWTH DYNAMICS ACROSS GLOBAL NUTRACEUTICAL EXCIPIENT INDUSTRY IN RESPONSE TO EVOLVING FORMULATION DEMANDS 73 FIGURE 22 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS 73 FIGURE 23 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 76 FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION, 2020–2024 (USD/KG) 79 FIGURE 25 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 80 FIGURE 26 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 81 FIGURE 27 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 82 FIGURE 28 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 82 FIGURE 29 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 83 FIGURE 30 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 84 FIGURE 31 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 85 FIGURE 32 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 86 FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 87 FIGURE 34 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION) 88 FIGURE 35 NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024 97 FIGURE 36 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024 98 FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT TYPE 132 FIGURE 38 KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT 133 FIGURE 39 PROTEIN & AMINO ACIDS TO LEAD DURING FORECAST PERIOD 137 FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 149 FIGURE 41 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025 VS. 2030 172 FIGURE 42 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025 VS. 2030 (USD MILLION) 180 FIGURE 43 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION) 187 FIGURE 44 ITALY, CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 202 FIGURE 45 NORTH AMERICA: MARKET SNAPSHOT 204 FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT 228 FIGURE 47 NUTRACEUTICAL EXCIPIENTS MARKET: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION) 261 FIGURE 48 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL EXCIPIENTS MARKET, 2024 263 FIGURE 49 BRAND/PRODUCT COMPARISON 264 FIGURE 50 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 267 FIGURE 51 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT 268 FIGURE 52 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 274 FIGURE 53 COMPANY VALUATION OF KEY NUTRACEUTICAL EXCIPIENTS MANUFACTURERS 277 FIGURE 54 EV/EBITDA OF KEY COMPANIES 277 FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 285 FIGURE 56 INGREDION: COMPANY SNAPSHOT 290 FIGURE 57 BASF SE: COMPANY SNAPSHOT 294 FIGURE 58 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 299 FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT 304 FIGURE 60 CARGILL, INCORPORATED: COMPANY SNAPSHOT 309 FIGURE 61 AZELIS: COMPANY SNAPSHOT 314 FIGURE 62 ASHLAND: COMPANY SNAPSHOT 320 FIGURE 63 ROQUETTE FRÈRES: COMPANY SNAPSHOT 329 FIGURE 64 IMCD: COMPANY SNAPSHOT 352 FIGURE 65 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN 379 FIGURE 66 KEY DATA FROM PRIMARY SOURCES 381 FIGURE 67 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 382 FIGURE 68 KEY INSIGHTS FROM INDUSTRY EXPERTS 382 FIGURE 69 BRIEF OF BOTTOM-UP APPROACH 384 FIGURE 70 NUTRACEUTICAL EXCIPIENTS MARKET: BOTTOM-UP APPROACH 385 FIGURE 71 NUTRACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH 386 FIGURE 72 BRIEF OF TOP-DOWN APPROACH 387 FIGURE 73 DATA TRIANGULATION 388 FIGURE 74 FACTOR ANALYSIS 389 FIGURE 75 RESEARCH ASSUMPTIONS 390 FIGURE 76 RESEARCH LIMITATIONS 391

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Nutraceutical Excipients Market by Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Fillers & Diluents, Disintegrants, Coating Agents), End Product, Formulation, Functionality Application and Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（食品與飲料）